Florida Clinical Research Center

Bradenton, Florida 34208

0 studies enrolling now · 14 studies all time

What they study most

ADHD, Acute Migraine, Anxiety Disorder, Anxiety, Separation, Attention Deficit Disorder With Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder, Conduct Disorder, Depression, Generalized Anxiety Disorder (GAD), Major Depressive Disorder, Phobia, Social

Studies at this site

• Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems — Completed
• Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder — Completed
• SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP) — Completed
• The Efficacy and Safety of PRC-063 in Adult ADHD Patients — Completed
• Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia — Completed
• DFN-02 Open Label Safety Study in Patients With Acute Migraine — Completed
• NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) — Completed
• Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder — Completed
• Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. — Completed
• Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD — Completed
• PRC-063 in Adolescent ADHD — Completed
• Experimental Medication For the Treatment of Generalized Anxiety Disorder — Completed
• Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) — Completed
• A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder — Completed